Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
80.9M
-
Shares change
-
+5.5M
-
Total reported value, excl. options
-
$1.04B
-
Value change
-
+$53.1M
-
Put/Call ratio
-
0.37
-
Number of buys
-
75
-
Number of sells
-
-50
-
Price
-
$12.80
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q2 2018
147 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q2 2018.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.9M shares
of 334M outstanding shares and own 24.19% of the company stock.
Largest 10 shareholders include venBio Select Advisor LLC (8.18M shares), BlackRock Inc. (6.3M shares), PERCEPTIVE ADVISORS LLC (5.85M shares), ORBIMED ADVISORS LLC (5.55M shares), FRANKLIN RESOURCES INC (5.31M shares), FARALLON CAPITAL MANAGEMENT LLC (4.43M shares), Broadfin Capital, LLC (4.15M shares), ACUTA CAPITAL PARTNERS, LLC (4.03M shares), STATE STREET CORP (3.86M shares), and VANGUARD GROUP INC (3.75M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.